Latest

alpha-synuclein

Featured Neurology

·April 19, 2018·5 min read

Concussion May Increase Parkinson’s Risk

A new study reveals veterans who suffered a concussion are at a 56% increased risk of developing Parkinson's disease.

Featured Neurology Open Neuroscience Articles

·April 6, 2018·4 min read

New Blood Test Useful to Detect Those at Risk of Developing Alzheimer’s

Researchers have developed a new blood test capable of detecting biomarkers of Alzheimer's disease long before the first symptoms appear.

Featured Neurology

·February 23, 2018·2 min read

Shedding a Tear May Help Diagnose Parkinson’s

Researchers report analyzing a person's tears may help doctors diagnose Parkinson's disease. The study reveals those with Parkinson's had increased levels of oligomeric alpha synuclein in their tears compared to those without the neurodegenerative disease.

Featured Neurology Open Neuroscience Articles

·February 19, 2018·4 min read

Calcium May Play a Role in the Development of Parkinson’s

A new Nature Communications study reveals increased calcium levels in brain cells may play a significant role in the development of Parkinson's disease.

Featured Neurology Open Neuroscience Articles

·December 20, 2017·4 min read

Findings Point to Potential New Therapy for Parkinson’s

A new PNAS study reveals an FDA approved drug that targets toxic protein interactions could be used as a novel treatment for Parkinson's disease.

Featured Neurology Open Neuroscience Articles

·September 28, 2017·6 min read

Parkinson’s Involves Degeneration of the Olfactory System

Max Planck researchers have made a groundbreaking discovery that helps explain why people with Parkinson's often report an impaired sense of smell. They discovered the total volume of glomeruli in the olfactory bulb of Parkinson's patients is only half of that found in people without the disease.

Image shows alpha-synuclein amyloid fibrils.

Featured Neurology Open Neuroscience Articles

·September 14, 2017·3 min read

Molecular Link Between Parkinson’s and Prion Diseases Discovered

Researchers detail the complex interaction between alpha synuclein and the prion protein PrPc.

Featured Neurology

·September 5, 2017·4 min read

Longtime Antidepressant Could Slow Parkinson’s Progression

According to researchers, an antidepressant that has been available for more than 50 years could help slow the progression of Parkinson's disease. The drug, nortiptyline, has been shown to stop the growth of alpha synuclein.

Featured Neurology

·August 29, 2017·5 min read

Altered Gut Microbiome Could Indicate Parkinson’s Disease

Even during early stages of the disease, gut bacteria in those with Parkinson's differs significantly from those without the disease, a new study reports.

Featured Genetics Neuroscience Open Neuroscience Articles Psychology

·August 10, 2017·6 min read

Hormone Shows Promise as Cognition Enhancer

Researchers report klotho, a life extending protein, improved working memory, spatial memory and learning in mice. The researchers also noted a single injection of klotho was sufficient to improve cognitive ability and the effects were long lasting.

Featured Neurology

·July 28, 2017·4 min read

A New Insight into Parkinson’s Disease Protein

A Nature Neuroscience study reveals the normal role of alpha-synuclein, a protein implicated in Parkinson's disease. Researchers say understanding how the protein normally acts may give insights into how it might fail.

Featured Neurology

·July 27, 2017·3 min read

Immune System May Mount Attack in Parkinson’s

Researchers report T cells in Parkinson's disease patients respond to alpha synuclein to a greater degree than those without the disease. The Nature study reports four genetic variations are associated with T cell reactivity to alpha synuclein. More than 50% of Parkinson's patients carry at least one of the gene variants.